Month: May 2014
Law Firm Investigates Claims That Abilify Causes Compulsive Gambling
Abilify or Aripiprazole was developed by Japan’s Otsuka Pharmaceutical Company and approved by the U.S. Food and Drug Administration in 2002 for the treatment of depression, schizophrenia, bipolar disorder and irritability associated with autism. In the U.S., the drug is...